1. Home
  2. ASMB vs NPV Comparison

ASMB vs NPV Comparison

Compare ASMB & NPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • NPV
  • Stock Information
  • Founded
  • ASMB 2005
  • NPV 1993
  • Country
  • ASMB United States
  • NPV United States
  • Employees
  • ASMB N/A
  • NPV N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • NPV Investment Managers
  • Sector
  • ASMB Health Care
  • NPV Finance
  • Exchange
  • ASMB Nasdaq
  • NPV Nasdaq
  • Market Cap
  • ASMB 225.9M
  • NPV 208.1M
  • IPO Year
  • ASMB 2010
  • NPV N/A
  • Fundamental
  • Price
  • ASMB $37.28
  • NPV $11.21
  • Analyst Decision
  • ASMB Strong Buy
  • NPV
  • Analyst Count
  • ASMB 6
  • NPV 0
  • Target Price
  • ASMB $43.40
  • NPV N/A
  • AVG Volume (30 Days)
  • ASMB 133.7K
  • NPV 38.9K
  • Earning Date
  • ASMB 11-10-2025
  • NPV 01-01-0001
  • Dividend Yield
  • ASMB N/A
  • NPV 3.90%
  • EPS Growth
  • ASMB N/A
  • NPV N/A
  • EPS
  • ASMB N/A
  • NPV N/A
  • Revenue
  • ASMB $37,191,000.00
  • NPV N/A
  • Revenue This Year
  • ASMB $14.29
  • NPV N/A
  • Revenue Next Year
  • ASMB N/A
  • NPV N/A
  • P/E Ratio
  • ASMB N/A
  • NPV N/A
  • Revenue Growth
  • ASMB 31.30
  • NPV N/A
  • 52 Week Low
  • ASMB $7.75
  • NPV $8.92
  • 52 Week High
  • ASMB $39.71
  • NPV $11.55
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 66.12
  • NPV 40.86
  • Support Level
  • ASMB $35.50
  • NPV $11.11
  • Resistance Level
  • ASMB $39.65
  • NPV $11.24
  • Average True Range (ATR)
  • ASMB 2.14
  • NPV 0.10
  • MACD
  • ASMB 0.05
  • NPV -0.02
  • Stochastic Oscillator
  • ASMB 72.27
  • NPV 27.91

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About NPV Nuveen Virginia Quality Municipal Income Fund

Nuveen Virginia Quality Municipal Income Fund is a diversified closed-end management investment company. The fund seeks to provide current income exempt from both regular federal and designated state income taxes. The fund invests in a portfolio of municipal obligations issued by state and local government authorities. Company mostly invest in Education and Civic Organizations, Tax Obligation/General, Healthcare, Utilities , Housing/Multifamily, Transportation, and Others.

Share on Social Networks: